La Jolla Pharmaceutical Company
LJPC
LJPC was delisted on the 19th of August, 2022.
72 hedge funds and large institutions have $447M invested in La Jolla Pharmaceutical Company in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 31 increasing their positions, 12 reducing their positions, and 3 closing their positions.
633% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 3
158% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 12
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
96% more call options, than puts
Call options by funds: $4.65M | Put options by funds: $2.37M
68% more capital invested
Capital invested by funds: $266M → $447M (+$180M)
36% more funds holding
Funds holding: 53 → 72 (+19)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$27M |
| 2 |
RI
RTW Investments
New York
|
+$25.1M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$14.7M |
| 4 |
PA
Perceptive Advisors
New York
|
+$12.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$2.66M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$2.29M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$787K |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$475K |
| 5 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$473K |
LJPC Hedge Fund Activity: Q3 2015 in Review
72 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q3 2015, worth a combined $447M — up 68% from $266M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new LJPC positions and 3 closed out — a net gain of 19 holders — while 31 added to existing stakes and 12 trimmed.
The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $27M. The largest seller was D.E. Shaw & Co, cutting an estimated $2.66M.
- 72 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q3 2015, up from 53 in Q2 2015.
- Funds reported $447M of La Jolla Pharmaceutical Company stock for Q3 2015, up 68% quarter-over-quarter.
- 22 funds opened new La Jolla Pharmaceutical Company positions in Q3 2015 and 3 closed out, a net change of +19 holders.
- The largest La Jolla Pharmaceutical Company buyer in Q3 2015 was Janus Henderson Investors US, an estimated $27M added.
- The largest La Jolla Pharmaceutical Company seller in Q3 2015 was D.E. Shaw & Co, an estimated $2.66M sold.
Based on aggregated 13F filings for Q3 2015.